BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
BLRX | TA
Overview
Corporate Details
- ISIN(s):
- US09071M2052 (+1 more)
- LEI:
- 529900AKIOSC15Y63R18
- Country:
- Israel
- Address:
- Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
- Website:
- https://www.biolinerx.com/
- Sector:
- Manufacturing
Description
BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-28 01:29 |
Convening of annual meeting to be held on 03/07/2022
|
English | 155.0 KB | ||
| 2022-05-28 01:29 |
Convening of annual meeting to be held on 03/07/2022
|
English | 520.8 KB | ||
| 2022-05-28 01:29 |
Convening of annual meeting to be held on 03/07/2022
|
English | 173.4 KB | ||
| 2022-05-11 16:04 |
FORM 6-K-Reports First Quarter 2022 Financial Results
|
English | 287.9 KB | ||
| 2022-05-11 16:04 |
FORM 6-K-Reports First Quarter 2022 Financial Results
|
English | 35.9 KB | ||
| 2022-03-16 14:19 |
Form 20-F 2021
|
English | 1.7 MB | ||
| 2022-03-16 14:19 |
Form 20-F 2021
|
English | 35.9 KB | ||
| 2022-03-16 14:16 |
BioLineRx Reports Fourth Quarter 2021 Financial Results and Provides Corporate …
|
English | 138.1 KB | ||
| 2022-03-16 14:16 |
BioLineRx Reports Fourth Quarter 2021 Financial Results and Provides Corporate …
|
English | 36.0 KB | ||
| 2022-03-03 14:59 |
BioLineRx Announces Additional Positive Results from
Pharmacoeconomic Study Com…
|
English | 120.9 KB | ||
| 2022-03-03 14:59 |
BioLineRx Announces Additional Positive Results from
Pharmacoeconomic Study Com…
|
English | 36.1 KB | ||
| 2022-01-24 14:59 |
BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative …
|
English | 71.0 KB | ||
| 2022-01-24 14:59 |
BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative …
|
English | 36.1 KB | ||
| 2022-01-18 14:59 |
BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motix…
|
English | 137.3 KB | ||
| 2022-01-18 14:59 |
BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motix…
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioLineRx Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
